Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pot remains Europe’s most used drug

By Pharmaceutical Processing | June 4, 2015

LISBON, Portugal (AP) — Marijuana continues to be the European Union’s most commonly used drug, with almost 79 million EU citizens estimated to have tried it at some point in their lives, the bloc’s drug agency said in a report published Thursday.

That is almost a quarter of the EU’s adult population and compares with some 15.6 million who have tried cocaine, the second most popular drug, the Lisbon, Portugal-based agency said.

The annual European Drug Report said marijuana accounts for 80 percent of drug seizures on the continent and 60 percent of all reported drug law offenses.

The European Monitoring Center for Drugs and Drug Addiction also noted that while recent laws allowing the regulated sale of marijuana in some parts of North and South America have drawn wide interest and debate among drug experts, attention in Europe is still centered on the drug’s potential health costs.

Organized crime groups are becoming more deeply involved in marijuana production and trafficking, making it a drug of growing importance for law enforcement agencies, the report said.

At the same time, there are increasing cases of serious health problems linked to high-potency cannabis products. The agency has recorded increases in the purity or potency of all the most commonly used drugs in Europe.

Last year, authorities identified 101 new synthetic drugs, up from 80 discovered the previous year. The new substances are not controlled under international law and are commonly sold as “legal highs,” often over the Internet. They try to mimic the effects of controlled drugs such as cocaine or LSD.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE